China Biotech Services Holdings
China Biotech Services Holdings Limited, commonly referred to as CBSH, is a prominent player in the biotechnology sector, headquartered in China (CN). Established in 2001, the company has made significant strides in providing comprehensive services across the biopharmaceutical and healthcare industries, focusing on drug development, clinical trials, and regulatory compliance. With a strong operational presence in major regions of China, CBSH offers a unique suite of services that includes laboratory testing, data management, and consulting. Their commitment to innovation and quality has positioned them as a trusted partner for pharmaceutical companies seeking to navigate the complexities of the biotech landscape. Notable achievements include successful collaborations with leading global firms, underscoring their market position as a key service provider in the rapidly evolving biotech industry.
DitchCarbon Score
How does China Biotech Services Holdings's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
China Biotech Services Holdings's score of 9 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
China Biotech Services Holdings's reported carbon emissions
In 2023, China Biotech Services Holdings reported significant carbon emissions, with Scope 1 emissions amounting to approximately 9,383,709,020 kg CO2e, Scope 2 emissions at about 286,889,120 kg CO2e, and Scope 3 emissions reaching approximately 9,670,598,140 kg CO2e. This data indicates a substantial carbon footprint across all scopes, particularly in Scope 3, which encompasses indirect emissions from the value chain. In previous years, the company demonstrated varying emissions levels, with total emissions recorded at approximately 11,273,000 kg CO2e in 2022, 238,000 kg CO2e in 2021, and 465,000 kg CO2e in 2020. Notably, the emissions in 2019 were about 541,000 kg CO2e, while in 2018, they were approximately 431,000 kg CO2e. The trend shows fluctuations in emissions, with a peak in 2022. Despite these figures, there are currently no publicly disclosed reduction targets or climate pledges from China Biotech Services Holdings. The absence of specific initiatives or commitments suggests a need for enhanced focus on sustainability and carbon reduction strategies within the organisation. As the industry increasingly prioritises climate action, the company may benefit from establishing clear targets to align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 27,000 | 00,000 | 00,000 | 00,000 | 0,000 | 0,000,000,000 |
| Scope 2 | 404,000 | 000,000 | 000,000 | 000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | - | 00,000 | 00,000 | 00,000 | 00,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
China Biotech Services Holdings is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
